InflaRx GmbH (IFRX): Total Asset Value of Company
The high barrier to entry in the complement inhibition niche is driven by expensive development costs and patent protection for antibodies. The visualization of the market price of total assets, which reached 0.00, underscores the scale of InflaRx N.V. (IFRX), a business currently facing logistical challenges in Europe and export restrictions. The stability of InflaRx N.V. (IFRX) relies on the drug Gohibic, which is FDA-approved for intensive care units, although the expansion of the clinic network is constrained by strict regulatory requirements.
Comprehensive metric breakdowns and analytics for inflarx.de (IFRX)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:IFRX, InflaRx GmbH
This indicator reflects the total value of InflaRx N.V. resources, calculated inversely via return on assets (ROA) to assess business sustainability under credit pressure. The asset dynamics of InflaRx N.V. demonstrate the expansion rate of the base for costly R&D, which is critical for the company when creating patent-protected antibodies and overcoming high regulatory barriers in emergency medicine.
Competitors of InflaRx N.V. (IFRX)
ARGX (argenx.com) - Total Business Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|SEPN: Company Total Assets|Company Assets Pieris Pharma PVLA|Company Total Assets SVRA (Savara Corp)|RIGL: Company Total Asset Base|Aggregate Company Assets AnaptysBio, Inc.|astriatx.com (ATXS) - Total Business Assets|Company Total Assets enGene ENGN|Total Asset Value of Company RAPT|Aggregate Company Assets Aerovate Therapeutics Inc (JBIO)|Aggregate Company Assets Aclaris Therapeutics, Inc (ACRS)|Company Total Assets KYTX (Kyverna Therapeutics)|tizianalifesciences.com - Company Total Assets|Aggregate Company Assets Cabaletta Bio (CABA)|Ventyx Biosciences Inc. (VTYX) - Aggregate Asset Value|Cumulative Company Assets Theratechnologies Inc|Total Business Assets Avalo Therapeutics Inc|ELDN - Cumulative Company Assets|Aggregate Asset Value AGEN|Aggregate Company Assets Climb Bio CLYM|Total Business Assets Zura Bio Ltd ZURA|Cumulative Company Assets ATYR|ADAG - Company Total Asset Base|IMA - Cumulative Company Assets|Shattuck Labs, Inc. (STTK) - Aggregate Company Assets|equilliumbio.com - Cumulative Company Assets|Connect Biopharma Holdings Limited (CNTB) - Company Total Asset Base|IMUX: Company Total Assets|Company Total Asset Base Atara Biotherapeutics Inc|XFOR - Company Total Assets|Total Asset Value of Company ACET (adicetbio.com)|Aggregate Company Assets Celularity|INMB - Aggregate Asset Value|Barinthus Bio (BRNS) - Cumulative Company Assets|KZR: Total Business Assets|Aggregate Company Assets SAB Biotherapeutics (SABS)|akaritx.com (AKTX) - Total Asset Value of Company|ENLV - Company Total Assets|Aggregate Asset Value Q32 Bio Corp|Company Total Assets GOVX|Company Total Assets EDSA (Edesa Biotech Corp)|Aggregate Company Assets iBio, Inc.|Carisma Therapeutics Inc - Aggregate Asset Value|XTLB: Aggregate Company Assets|BOLT - Cumulative Company Assets|HCWB: Company Total Assets|Company Total Assets Aptevo Therapeutics Inc.|AIM - Cumulative Company Assets|Aggregate Asset Value Aditxt Corp|GRI (GRI Bio) - Company Total Assets|Company Total Asset Base XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences - Aggregate Company Assets|Revelation Biosciences Corp - Cumulative Company Assets|INDP: Aggregate Company Assets|scinai.com (SCNI) - Cumulative Company Assets|CALI: Cumulative Company Assets|AFMD (Affimed N.V.) - Company Total Assets|Aggregate Company Assets Allakos Inc (ALLK)|Total Business Assets HOOKIPA|IGM Biosciences, Inc. - Company Total Assets|Company Assets iteostherapeutics.com (ITOS)|Company Total Assets OCEA|TC BioPharm (Holdings) Plc - Company Total Asset Base|Third Harmonic Bio, Inc (THRD) - Aggregate Company Assets